Listen to this story
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowThis audio file is brought to you by 
0:00
0:00
Loading audio file, please wait.
Mickey Maurer’s [Nov. 26] commentary details a very rosy outlook for the future of Endocyte, the Indiana biopharmaceutical company. His clear message is, he believes the stock is going up and readers should get in now.
I have no interest in Endocyte nor do I own any stock in the company. I just question how a rich guy who owns his own newspaper can use it to “pump” a stock he owns. Seems like a great way for Maurer to create buying interest in a stock after he has his shares.
__________
Mike Sechrist
Please enable JavaScript to view this content.